Amgen Inc. - Company & Market Research Reports

Home /
Companies /
Amgen Inc.

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 337
Immune Disorders Drugs 208
Biopharmaceuticals 178
Musculoskeletal Disorders Drugs 128
Genomics 116
Cardiovascular Drugs 104
Drug Discovery 84
Biotechnology 83
Pharmaceuticals 83
Endocrine and Metabolic Disorders Drugs 74
Biosimilars and Biosuperiors 73
Allergy and Immunology 66
Infusions and Injectables 66
Leukemia Drugs 65
Hematological Drugs 60
Clinical Trials 54
Oncology 52
Dermatological Drugs 51
Central Nervous System Drugs 49
Women's Health 45
Liver and Kidney Disorders Drugs 44
Needles and Syringes 42
Drug Delivery 37
Psoriasis Drugs 37
Diagnostics 36
Skin Cancer Drugs 35
Hematology 30
Infectious Diseases Drugs 27
Colon Cancer Drugs 27
Brain Cancer Drugs 27
Proteomics 27
Enzymes 27
Gastrointestinal Drugs 27
Lung Cancer Drugs 26
Immunosuppressive Drugs 25
Lymphoma Drugs 23
Analgesics 23
Drugs by Therapeutic Area 19
Dermatology 19
Pharmaceutical Manufacturing 19
Respiratory Drugs 18
Therapeutic Area 16
Optical 16
Urology and Nephrology 15
Healthcare Services 14
Kidney Cancer Drugs 14
Optical Disorders Drugs 13
Prostate Cancer Drugs 12
Pancreatic Cancer Drugs 12
Nanomedicine 11
Generic Drugs 10
Breast Cancer Drugs 10
Ovarian Cancer Drugs 10
Cervical Cancer Drugs 10
Cardiology 10
Sexual and Reproductive Health Drugs 10
E-Healthcare 9
Pulmonary Medicine 8
Liver Cancer Drugs 8
Cancer Vaccines 8
Other Healthcare Facilities 8
Anti-Obesity Drugs 8
In Vitro Diagnostics 7
Biomarkers 7
Gastroenterology 7
Diabetes Drugs 6
Biomaterials 6
Vaccines 6
Mental Disorders Drugs 6
Company Reports 5
Animal Pharmaceuticals 5
Pharmaceutical Intermediates 5
Neurology 5
Medical Devices 5
Molecular Diagnostics 5
Over the Counter (OTC) Drugs 5
Pediatrics 5
Asthma Drugs 5
Surgical Procedures 4
Thyroid Cancer Drugs 4
Alzheimer's Disease Drugs 4
Bladder Cancer Drugs 3
Managed Care 3
Stem Cells 3
Endocrinology 3
Addiction Disorders Drugs 2
Cardiovascular Devices 2
Infectious Disease Testing 2
Inhalers and Nebulisers 2
Mental Health 2
Uterine Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Antibiotics 2
Acne Drugs 2
Urological Disorders Drugs 2
Schizophrenia Drugs 2
Hepatology 1
Pharmacoeconomics 1
Fertility Services 1
Bioinformatics 1
Orthopedic Devices 1
Cholesterol Testing 1
Cough and Cold Drugs 1
Healthcare 1
Radiography 1
Transdermal and Transmucosal Drug Delivery 1
Blood Banking 1
Hospital Management 1
Respiratory Devices 1
Clinical Therapies 1
Clinical Skills 1
Palliative Care 1
Anatomy 1
Maternal and Neonatal Care 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,104 Results (Page 49 of 106)
- Relevance
  Sort by

Glioblastoma Multiforme Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
120 Pages
Global

From

€4254EUR$4,750USD£3,734GBP

Colorectal Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

 Report
February 2024
172 Pages
Global

From

€4030EUR$4,500USD£3,537GBP

Regenerative Medicine Collaboration and Licensing Deals 2019-2025

 Report
May 2025
700 Pages
Global

From

€3578EUR$3,995USD£3,140GBP

Protein Engineering Market 2024-2028

 Report
May 2024
177 Pages
Global

From

€2239EUR$2,500USD£1,965GBP

Protein Expression Market 2024-2028

 Report
May 2024
168 Pages
Global

From

€2239EUR$2,500USD£1,965GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Radiation Toxicity Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
March 2025
180 Pages
Global

From

€4030EUR$4,500USD£3,537GBP

Crohn Disease Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

 Report
March 2022
81 Pages
Global

From

€3500EUR$4,186USD£3,179GBP

Brain Metastases- Pipeline Insight, 2025

 Clinical Trials
April 2025
220 Pages
Global

From

€1791EUR$2,000USD£1,572GBP

€2239EUR$2,500USD£1,965GBP

Adult Malignant Glioma Therapeutics Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4021EUR$4,490USD£3,529GBP

Digital Health in Immunology - Thematic Research

 Report
December 2021
57 Pages
Global

From

€1746EUR$1,950USD£1,533GBP

Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
152 Pages
Global

From

€3135EUR$3,500USD£2,751GBP

Glioblastoma Multiforme (GBM) Treatment Market Report 2025

 Report
March 2025
175 Pages
Global

From

€4021EUR$4,490USD£3,529GBP

Malignant Glioma - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1433EUR$1,600USD£1,258GBP

€1791EUR$2,000USD£1,572GBP

Cutaneous T-Cell-Lymphoma Market - Global Forecast 2025-2030

 Report
August 2025
190 Pages
Global

From

€3175EUR$3,545USD£2,787GBP

€3528EUR$3,939USD£3,096GBP

Glioma Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4021EUR$4,490USD£3,529GBP

Lymphoma Therapeutics Market - Global Forecast 2025-2032

 Report
October 2025
192 Pages
Global

From

€3175EUR$3,545USD£2,787GBP

€3528EUR$3,939USD£3,096GBP

Nasal Drug Delivery Technology Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4021EUR$4,490USD£3,529GBP

Biopharmaceuticals - A Global Market Overview

 Report
February 2025
225 Pages
Global

From

€3224EUR$3,600USD£2,830GBP

€4030EUR$4,500USD£3,537GBP

T-Xell Lymphoma - Global Strategic Business Report

 Report
November 2025
281 Pages
Global

From

€5239EUR$5,850USD£4,598GBP

Aplastic Anemia - Global Strategic Business Report

 Report
November 2025
469 Pages
Global

From

€5239EUR$5,850USD£4,598GBP

2,104 Results (Page 49 of 106)
- 1
- 47
- 48
- 49
- 50
- 51

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.